Search Results
Dec 03, 2025, 07:30 ET DIAMONDROCK HOSPITALITY DECLARES FOURTH QUARTER DIVIDEND
Common Dividends for 2025 Total $0.36 Per Share, a 12.5% Increase over 2024BETHESDA, Md., Dec. 3, 2025 /PRNewswire/ -- DiamondRock Hospitality Company (the "Company" or "DiamondRock") (Nasdaq: DRH)
More news about: DiamondRock Hospitality Company
Dec 03, 2025, 07:30 ET ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA® in Combination with Bispecific Antibody Supporting Potential Best-in-Class Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma
profile and strong efficacy including deep and durable responses in 2L+ r/r DLBCL patients treated with ZYNLONTA plus glofitamab," said Mohamed Zaki, MD, PhD, Chief Medical Officer of ADC Therapeutics. "We are well on the way to completing enrollment of approximately 100 patients at the selected dose and
More news about: ADC Therapeutics SA
Dec 03, 2025, 07:05 ET AHN Allegheny General Hospital reports strong health outcomes for patients who can stand, walk while receiving heart-lung bypass therapy
Shan Modi, MD, cardiothoracic critical care physician and one of the program's lead physicians. "However, with this new focus on movement, and by carefully and safely
More news about: Allegheny Health Network
Dec 03, 2025, 07:00 ET MyOme and Ms.Medicine Announce Strategic Partnership to Redefine Personalized Primary Care Through Genomics
research. "Our mission has always been to elevate the standard-of-care by making it individualized, evidence-based, and proactive," said Lisa Larkin, MD, FACP, MSCP, IF, Chief Executive Officer of Ms.Medicine. "By integrating MyOme's comprehensive genomic testing through Nest's platform, our clinicians
More news about: MyOme, Inc
Dec 03, 2025, 07:00 ET GRIN Therapeutics to Present on Global Phase 3 Beeline Clinical Trial of Radiprodil at American Epilepsy Society Annual Meeting
Impression Scales Specific to the Common Signs and Symptoms of GRIN-Related Neurodevelopmental DisorderPresenter: Russell L. Chin, MD, Medical Director, GRIN TherapeuticsSession date/time: Tuesday, December 9, 2025, 12:00-1:45 p.m. ESTAdditional information about
More news about: GRIN Therapeutics Inc.
Dec 03, 2025, 06:45 ET TELUS provides three-year free cash flow growth target
be read together with the risk factors and assumptions set out in our 2024 annual management's discussion and analysis ("MD&A"), and updated in our third quarter 2025 MD&A, and in other TELUS public disclosure documents and filings with securities commissions in Canada (on SEDAR+ at
More news about: TELUS Corporation
Dec 03, 2025, 06:30 ET CGI expands its Winnipeg presence and Canadian footprint with the acquisition of Online Business Systems
in the section titled Risk Environment of CGI's annual MD&A, which is incorporated by reference in this cautionary statement. We also caution readers that the above-mentioned risks and the risks disclosed in CGI's annual MD&A and other documents and filings are not the only ones that could
More news about: CGI Inc.
Dec 03, 2025, 06:00 ET Realtor.com® 2026 Housing Forecast: Housing Market Remains Balanced as Supply and Demand Find Firmer Footing
Baltimore-Columbia-Towson, Md.-2.6 %
More news about: Realtor.com
Dec 03, 2025, 05:00 ET Synergy ECP Acquires Federal IT Solutions Leader NetServices
COLUMBIA, Md., Dec. 3, 2025 /PRNewswire/ -- Synergy
More news about: Synergy ECP
Dec 03, 2025, 04:00 ET SellYourWay.org Announces a New White Paper on Key Questions to Ask a Business Broker
vetting process — before engaging a Business Broker to manage the sale of their company. Mr. Bharad is President of Transworld Business Advisors RVA (VA, MD, DE, WV). SellYourWay.org is powered by the
More news about: Sell Your Way
Dec 03, 2025, 01:30 ET Welcome to the Era of High Life Worth: An Evolving Global Luxury Landscape Shapes Marriott International's Luxury Group Strategy for 2026 and Beyond
a vision centered on emotional resonance, transformative journeys, and purpose-driven luxury.BETHESDA, Md., Dec. 3, 2025 /PRNewswire/ -- From the International Luxury Travel Market (ILTM) in Cannes, Marriott International's
More news about: Marriott International, Inc.
Dec 02, 2025, 21:15 ET The Frederick Arts Council Presents "Where Energy Meets Matter: Exploring the Frontiers of Science" in partnership with the Frederick National Laboratory for Cancer Research
FREDERICK, Md., Dec. 2, 2025 /PRNewswire/ -- The "Where Energy Meets Matter" exhibition will run through January 20, 2026, at Gallery 115 located inside of the Y Arts Center (115 E Church St, Frederick, MD 21701).
More news about: Frederick Arts Council
Dec 02, 2025, 12:26 ET Dr. Rod J. Rohrich to Host 43rd Annual Dallas Rhinoplasty Meeting, March 20-22, 2026, at the Westin Galleria Dallas
model for surgical education, emphasizing anatomical precision and real-world application.The 2026 program will also feature the Jack P. Gunter, MD Distinguished Lecture, honoring the pioneering rhinoplasty surgeon who founded the meeting more than four decades ago and whose legacy continues to shape
More news about: Dr. Rod J. Rohrich
Dec 02, 2025, 12:00 ET Los Angeles Community Hospitals Named Among Top Ten Percent in the Nation for Overall Pulmonary Services by Healthgrades
nation's top-performing hospitals in key service areas, helping consumers find high quality care tailored to their specific needs," said Alana Biggers, MD, MPH, medical advisor at Healthgrades. "We're proud to recognize Los Angeles Community Hospitals for their consistently superior outcomes in key service
More news about: Los Angeles Community Hospitals
Dec 02, 2025, 11:26 ET Nexus Health Systems Names Jason James, MD, Chief Medical Officer
Nexus Health Systems has announced the appointment of Jason James, MD, as Chief Medical Officer. In this role, Dr. James will lead clinical strategy and operations across Nexus' network of hospitals and residential treatment
More news about: Nexus Health Systems
Dec 02, 2025, 11:00 ET New Tech Marks Major Advancement in Personalized Cancer Treatment
Bloomberg Briefing Room, National Press Club, Washington DCFREDERICK, Md., Dec. 2, 2025 /PRNewswire/ -- Researchers are unveiling a breakthrough lab technique that advances the new age
More news about: Nanocrine
Dec 02, 2025, 10:33 ET HeroX Facilitates NIH Common Fund's Advancement of Human-Based Research with New Validation Challenge
Available for Teams Demonstrating Real-World Readiness of Innovative Biomedical Research MethodsBETHESDA, Md., Dec. 2, 2025 /PRNewswire/ -- The National Institutes of Health (NIH) Common Fund, through NASA's Tournament
More news about: HeroX
Dec 02, 2025, 10:00 ET ALASKA AIRLINES DONATES 2 MILLION MILES TO RADY CHILDREN'S HEALTH TO ADVANCE PEDIATRIC HEALTHCARE
together."Thanks to Alaska Airlines, these miles will help us advance the exceptional pediatric care Rady Children's Health delivers every day," said Gail Knight, MD, Senior Vice President and Chief Medical Officer at Rady Children's Health in San Diego. "Alaska Airlines is going to help us do what we do best: teach
More news about: Rady Children's Hospital-San Diego
Dec 02, 2025, 09:38 ET Inner Haven Wellness Announces Major Expansion in Milwaukee, Bringing Physician-Led Eating Disorder Treatment to Wisconsin's Largest Metro Area
Margherita Mascolo, MD, CEDS, Chief Executive & Medical Officer. "We're building a space where clients feel deeply understood and medically supported, where their
More news about: Inner Haven Wellness
Dec 02, 2025, 09:30 ET Lung Cancer Research Foundation Announces 2025 Scientific Research Grant Awards
cancer therapyJohn Presner, MD, PhD, University of MichiganMicroproteins as novel disease targets in squamous cell lung cancerResearch Grant on Prevention and Early Detection in Lung Cancer:David Adler, MD, MPH, University of RochesterIncreasing
More news about: Lung Cancer Research Foundation
Dec 02, 2025, 09:18 ET Procyrion Appoints Andrew Davis as Chief Commercial Officer
DRAIN-HF pivotal trial continues to positively progress," said Eric S. Fain, MD, President and Chief Executive Officer of Procyrion. "Patients with diuretic-resistant heart failure who have failed currently available therapies remains
More news about: Procyrion
Dec 02, 2025, 09:10 ET Lunit to Highlight New AI Evidence in Cancer Screening and Breast Density-Driven Risk Modeling at RSNA 2025
EVOLUTION OF BREAST CANCER SCREENING: FROM HUMAN-ONLY DOUBLE READING VIA AI-INTEGRATED DOUBLE READING TO AI-INTEGRATED SINGLE READING—Karin Dembrower, MD, PhD, Karolinska Institute#6 S5-SSBR02,
More news about: Lunit
Dec 02, 2025, 09:02 ET Tennessee Oncology Appoints Dr. John Phillips EVP for Radiation Oncology Centers
John Phillips, MD, MPH has been appointed Executive Vice President of Radiation Oncology Centers. In this role, Dr. Phillips will oversee Tennessee Oncology's enterprise-wide
More news about: Tennessee Oncology
Dec 02, 2025, 09:00 ET Vaderis Therapeutics Announces The New England Journal of Medicine Publishes Engasertib Proof-of-Concept and Long-Term Extension Results, Highlighting the Therapy's Potential for Patients with Hereditary Hemorrhagic Telangiectasia
may be on a promising path toward a much-needed treatment option for this community, which remains without approved therapies," said Hanny Al-Samkari, MD, The Peggy S. Blitz Endowed Chair in Hematology/Oncology at the Mass General Brigham Cancer Institute, Associate Professor of Medicine at Harvard Medical
More news about: Vaderis Therapeutics AG
Dec 02, 2025, 09:00 ET Vaderis Therapeutics Announces The New England Journal of Medicine Publishes Engasertib Proof-of-Concept and Long-Term Extension Results, Highlighting the Therapy's Potential for Patients with Hereditary Hemorrhagic Telangiectasia
may be on a promising path toward a much-needed treatment option for this community, which remains without approved therapies," said Hanny Al-Samkari, MD, The Peggy S. Blitz Endowed Chair in Hematology/Oncology at the Mass General Brigham Cancer Institute, Associate Professor of Medicine at Harvard Medical
More news about: Vaderis Therapeutics AG